Skip to main content

Older adults

Hypoglycemia

Senior man with glucometer checking blood sugar

11-29-2022 | Older adults | News

Call to rethink CGM advice for older adults

Analysis of participants in the ORACL trial leads researchers to suggest that nonfrail older adults with type 1 diabetes are better off following time in range guidance aimed at younger people.

04-19-2022 | Older adults | News

Sustained benefits of CGM in older people with type 1 diabetes

Follow-up results from the WISDM trial show that extended use of continuous glucose monitoring leads to reduced hypoglycemia without increasing hyperglycemia risk in older people with type 1 diabetes.

02-14-2022 | Older adults | News

Type 1 diabetes duration linked to clinical, functional status in older adults

Older adults with a longer duration of type 1 diabetes have an increased likelihood of experiencing depression and hypoglycemia unawareness, researchers report.

11-04-2021 | Older adults | News | Article

Hospital discharge not best time to intensify diabetes medication in older adults

Intensification of diabetes medications in older adults at the point of discharge from hospital is associated with an increased risk for hypoglycemia, without gains in glycemic control, research suggests.

05-27-2021 | Older adults | News

Frailty upsets risk–benefit balance of intensive type 2 diabetes treatment

Researchers find diminished cardiovascular gains and an increased risk for severe hypoglycemia in frail people with type 2 diabetes given intensive glycemic and blood pressure treatment.

03-31-2021 | Older adults | News

Glargine-300 might be preferable for older people with type 2 diabetes

Analysis of older participants in the BRIGHT trial suggests that this subgroup may do slightly better with insulin glargine-300 than with degludec.

11-24-2020 | Older adults | News

Age has no impact on CV outcomes with linagliptin vs glimepiride

Cardiovascular event rates do not differ significantly among people with type 2 diabetes treated with linagliptin or glimepiride regardless of age, but those who receive linagliptin have lower risks for falls and hypoglycemia, CAROLINA trial data show.

emergency_department

08-03-2020 | Hypoglycemia | Highlight | News

Severe hypoglycemia ‘marker rather than cause’ for longer-term type 2 diabetes mortality risk

Severe hypoglycemia in people with type 2 diabetes is associated with later mortality from a wide range of causes, including those for which there is no obvious underlying mechanism, say researchers.

CGM

06-17-2020 | Continuous glucose monitoring | Highlight | News

Variable CGM benefits in high-risk subgroups

Continuous glucose monitoring is well accepted and reduces time in hypoglycemia among older individuals with type 1 diabetes, report researchers in JAMA.

01-15-2020 | Older adults | News

Severe hypoglycemia adversely affects brain health of older people with type 1 diabetes

Severe hypoglycemia may treble the risk for impaired cognitive function in older adults with type 1 diabetes, shows an analysis of data from the Study of Longevity in Diabetes.

09-24-2019 | Type 2 diabetes | Podcast | Article

How was it for you? The experts discuss EASD 2019

Our clinical advisors discuss their EASD 2019 highlights, including new treatment options for children and older adults with type 2 diabetes, the complexities surrounding hypoglycemia prevention, and the implications of the VERIFY trial.

08-16-2019 | Linagliptin | News

Add-on linagliptin improves glycemic control in older people with type 2 diabetes

The addition of linagliptin to stable insulin treatment improves glycemic control without increasing the risk for clinically important hypoglycemia among older individuals with type 2 diabetes, randomized trial findings suggest.

07-11-2019 | Insulin glargine | News

Support for Gla-300 use in older people with type 2 diabetes

Older type 2 diabetes patients receiving basal insulin treatment who switch to glargine 300 units/mL experience greater or similar improvements in glycemic control compared with those switching to a first-generation basal insulin, with lower hypoglycemia risk, researchers report.

03-25-2019 | Hypoglycemia | News

Problem of hypoglycemia unawareness highlighted in older people with type 1 diabetes

Baseline data from the WISDM trial show that older adults with type 1 diabetes who have impaired awareness of hypoglycemia symptoms can spend over half an hour per day with extremely low blood glucose levels.

Diabetes and dementia: Addressing the needs of an overlooked population

03-04-2019 | Mental health | Editorial | Article

Diabetes and dementia: Addressing the needs of an overlooked population

Diabetologist Amar Puttanna addresses growing concerns about the rise of dementia in diabetes care and highlights where guidelines, research efforts, and management options are needed to tackle this comorbidity.

06-24-2018 | Insulin degludec | ADA 2018 | News

Degludec benefits consistent in elderly patients

Degludec delivers the same magnitude of protection against hypoglycemia relative to glargine across patient age groups, shows analysis of the SWITCH 2 and DEVOTE trials.

06-06-2018 | Mental health | Article

The relationship between sleep and cognitive function in patients with prediabetes and type 2 diabetes

Saetung S et al. Acta Diabetol 2018. doi: 10.1007/s00592-018-1166-3

Elderly patient with doctor

06-06-2018 | Type 1 diabetes | Case report | Article

Sudden onset of immune-mediated type 1 diabetes mellitus in a 93-year-old woman: A case report

Oriot P et al. Acta Diabetol 2018. doi: 10.1007/s00592-018-1170-7

05-25-2018 | Diabetes self-management | Article

Type 1 diabetes self-management from emerging adulthood through older adulthood

McCarthy MM, Grey M. Diabetes Care 2018. doi: 10.2337/dc17-2597